Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma: Long-term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial.

Allogeneic hematopoietic cell transplantation (HCT) may improve long-term multiple myeloma (MM) control through graft vs myeloma (GVM) effect. The BMT CTN 0102 was a biological assignment trial comparing tandem autologous transplant (auto-auto) vs. autologous followed by reduced intensity allogeneic...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biol Blood Marrow Transplant
Glavni autori: Giralt, Sergio, Costa, Luciano J., Maloney, David, Krishnan, Amrita, Fei, Mingwei, Antin, Joseph H., Brunstein, Claudio, Geller, Nancy, Goodman, Stacey, Hari, Parameswaran, Logan, Brent, Lowsky, Robert, Qazilbash, Muzaffar H., Sahebi, Firoozeh, Somlo, George, Rowley, Scott, Vogl, Dan T., Vesole, David H, Pasquini, Marcelo, Stadtmauer, Edward
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7198329/
https://ncbi.nlm.nih.gov/pubmed/31756536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.11.018
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items